These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 22218453)
21. Biosimilars entering the clinic without animal studies. A paradigm shift in the European Union. van Aerts LA; De Smet K; Reichmann G; van der Laan JW; Schneider CK MAbs; 2014; 6(5):1155-62. PubMed ID: 25517301 [TBL] [Abstract][Full Text] [Related]
22. Biosimilars: Practical Considerations for Pharmacists. Stevenson JG; Popovian R; Jacobs I; Hurst S; Shane LG Ann Pharmacother; 2017 Jul; 51(7):590-602. PubMed ID: 28176529 [TBL] [Abstract][Full Text] [Related]
24. European perspective on biosimilars. Wadhwa M; Thorpe R Bioanalysis; 2013 Mar; 5(5):521-4. PubMed ID: 23425266 [No Abstract] [Full Text] [Related]
25. Scientific rationale behind the development and approval of biosimilar infliximab (CT-P13) in Europe. Müller-Ladner U; Hong S; Oh C; Taylor P Expert Rev Clin Immunol; 2015; 11 Suppl 1():S5-14. PubMed ID: 26395832 [TBL] [Abstract][Full Text] [Related]
26. The rise of the biosimilar. McCamish M; Woollett G Expert Rev Clin Pharmacol; 2012 Nov; 5(6):597-9. PubMed ID: 23234317 [No Abstract] [Full Text] [Related]
27. Comparability and biosimilarity: considerations for the healthcare provider. Lee JF; Litten JB; Grampp G Curr Med Res Opin; 2012 Jun; 28(6):1053-8. PubMed ID: 22519391 [TBL] [Abstract][Full Text] [Related]
28. American Society of Clinical Oncology Statement: Biosimilars in Oncology. Lyman GH; Balaban E; Diaz M; Ferris A; Tsao A; Voest E; Zon R; Francisco M; Green S; Sherwood S; Harvey RD; Schilsky RL J Clin Oncol; 2018 Apr; 36(12):1260-1265. PubMed ID: 29443651 [TBL] [Abstract][Full Text] [Related]
29. Implications of the FDA draft guidance on biosimilars for clinicians: what we know and don't know. Li E; Hoffman JM J Natl Compr Canc Netw; 2013 Apr; 11(4):368-72. PubMed ID: 23584340 [No Abstract] [Full Text] [Related]
30. On safety margin for drug interchangeability. Zheng J; Chow SC; Song F J Biopharm Stat; 2017; 27(2):293-307. PubMed ID: 27911675 [TBL] [Abstract][Full Text] [Related]
31. Biosimilar safety considerations in clinical practice. Choy E; Jacobs IA Semin Oncol; 2014 Feb; 41 Suppl 1():S3-14. PubMed ID: 24560025 [TBL] [Abstract][Full Text] [Related]
32. Frontiers in nonclinical drug development: biosimilars. Ryan AM Vet Pathol; 2015 Mar; 52(2):419-26. PubMed ID: 25161206 [TBL] [Abstract][Full Text] [Related]
33. Nonparametric tests for evaluation of biosimilarity in variability of follow-on biologics. Zhang N; Yang J; Chow SC; Chi E J Biopharm Stat; 2014; 24(6):1239-53. PubMed ID: 25036940 [TBL] [Abstract][Full Text] [Related]
35. Epoetin biosimilars in Europe: five years on. Mikhail A; Farouk M Adv Ther; 2013 Jan; 30(1):28-40. PubMed ID: 23242745 [TBL] [Abstract][Full Text] [Related]
36. Biosimilars in rheumatology: the wind of change. Schneider CK Ann Rheum Dis; 2013 Mar; 72(3):315-8. PubMed ID: 23390018 [No Abstract] [Full Text] [Related]
37. Biosimilars: biologics that meet patients' needs and healthcare economics. McCamish M; Yoon W; McKay J Am J Manag Care; 2016 Sep; 22(13 Suppl):S439-S442. PubMed ID: 28719221 [TBL] [Abstract][Full Text] [Related]
38. The Tortoise and the Hare: Evolving Regulatory Landscapes for Biosimilars. Konara CS; Barnard RT; Hine D; Siegel E; Ferro V Trends Biotechnol; 2016 Jan; 34(1):70-83. PubMed ID: 26620970 [TBL] [Abstract][Full Text] [Related]
39. Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future. Grabowski HG; Guha R; Salgado M Health Aff (Millwood); 2014 Jun; 33(6):1048-57. PubMed ID: 24889955 [TBL] [Abstract][Full Text] [Related]
40. Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13. Schreiber S; Panés J; Kwon B; Hong S; Peyrin-Biroulet L Expert Rev Gastroenterol Hepatol; 2015; 9 Suppl 1():5-15. PubMed ID: 26395530 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]